» Articles » PMID: 31496051

HIV Viral Suppression Among Pregnant and Breastfeeding Women in Routine Care in the Kinshasa Province: a Baseline Evaluation of Participants in CQI-PMTCT Study

Overview
Journal J Int AIDS Soc
Date 2019 Sep 10
PMID 31496051
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Published data on viral suppression among pregnant and breastfeeding women in routine care settings are scarce. Here, we report provincial estimates of undetectable and suppressed viral load among pregnant or breastfeeding women in HIV care in Kinshasa, Democratic Republic of Congo (DRC) and associated risk factors.

Methods: This cross-sectional study was conducted as part of a baseline assessment for the CQI-PMTCT study: an ongoing cluster randomized trial to evaluate the effect of continuous quality interventions (CQI) on long-term ART outcomes among pregnant and breastfeeding women (NCT03048669). From November 2016 to June 2018, in each of the 35 Kinshasa provincial health zones (HZ), study teams visited the three busiest maternal and child health clinics, enrolled all HIV-positive pregnant or breastfeeding women (≤1 year post-delivery) receiving ART, and performed viral load testing. Log binomial models with generalized estimating equations to account for clustering at the HZ level, were used to estimate prevalence ratios comparing participants with undetected (<40 copies/mL) or suppressed (<1000 copies/mL) viral load across levels of individual and site characteristics.

Results: Of the 1752 eligible women, 1623 had viral load results available, including 38% who had been on ART for <6 months and 74% were on tenofovir-lamivudine-efavirenz. Viral load was undetectable in 53% of women and suppressed in 62%. Among women who were on ART for ≥12 months, only 60% and 67% respectively, had undetectable or suppressed viral load. Viral load was undetectable in 53%, 48% and 58% of women testing during pregnancy, at delivery, and in postpartum respectively. In multivariable log binomial models, duration of ART >12 months, older age, being married, disclosure of HIV status, receiving care in an urban health zone or one supported by PEPFAR were all positively associated with viral suppression.

Conclusions: The observed high level of detectable viral load suggests that high ART coverage alone without substantial efforts to improve the quality of care for pregnant and breastfeeding women, will not be enough to achieve the goal of virtual elimination of vertical HIV transmission in high-burden and limited resources settings like DRC.

Citing Articles

Association of comprehensiveness of antiretroviral care and detectable HIV viral load suppression among pregnant and postpartum women in the Democratic Republic of the Congo: a cross-sectional study.

Boisson-Walsh A, Ravelomanana N, Tabala M, Malongo F, Kawende B, Babakazo P Front Glob Womens Health. 2024; 5:1308019.

PMID: 38903153 PMC: 11188341. DOI: 10.3389/fgwh.2024.1308019.


Viral load non-suppression status among women exposed to Dolutegravir-based versus Efavirenz-based regimens in Ethiopia: A before-and-after study.

Facha W, Tadesse T, Wolka E, Astatkie A PLoS One. 2024; 19(6):e0305331.

PMID: 38857273 PMC: 11164349. DOI: 10.1371/journal.pone.0305331.


Understanding mother-to-child transmission of HIV among mothers engaged in HIV care in Kenya: a case report.

Tuthill E, Odhiambo B, Maltby A Int Breastfeed J. 2024; 19(1):14.

PMID: 38395878 PMC: 10893718. DOI: 10.1186/s13006-024-00622-3.


Human Immunodeficiency Virus Viral Load Monitoring and Rate of Virologic Suppression Among Patients Receiving Antiretroviral Therapy in Democratic Republic of the Congo, 2013-2020.

Ngongo N, Kamangu Ntambwe E, Situakibanza Nani-Tuma H, Mambimbi M, Ndona M, Mashi M Open Forum Infect Dis. 2023; 10(6):ofad242.

PMID: 37363052 PMC: 10287095. DOI: 10.1093/ofid/ofad242.


Sexual violence and antiretroviral adherence among women of reproductive age in African population-based surveys: the moderating role of the perinatal phase.

Schrubbe L, Stockl H, Hatcher A, Calvert C J Int AIDS Soc. 2023; 26(6):e26129.

PMID: 37306126 PMC: 10258861. DOI: 10.1002/jia2.26129.


References
1.
Myer L, Dunning L, Lesosky M, Hsiao N, Phillips T, Petro G . Frequency of Viremic Episodes in HIV-Infected Women Initiating Antiretroviral Therapy During Pregnancy: A Cohort Study. Clin Infect Dis. 2016; 64(4):422-427. PMC: 5849096. DOI: 10.1093/cid/ciw792. View

2.
Gichane M, Moracco K, Thirumurthy H, Okitolonda E, Behets F, Yotebieng M . Intimate partner violence and prevention of mother to child transmission of HIV: Evidence from Kinshasa, Democratic Republic of Congo. PLoS One. 2018; 13(8):e0203471. PMC: 6117078. DOI: 10.1371/journal.pone.0203471. View

3.
Pannus P, Claus M, Gonzalez M, Ford N, Fransen K . Sensitivity and specificity of dried blood spots for HIV-1 viral load quantification: A laboratory assessment of 3 commercial assays. Medicine (Baltimore). 2016; 95(48):e5475. PMC: 5134769. DOI: 10.1097/MD.0000000000005475. View

4.
Yotebieng M, Thirumurthy H, Moracco K, Edmonds A, Tabala M, Kawende B . Conditional Cash Transfers to Increase Retention in PMTCT Care, Antiretroviral Adherence, and Postpartum Virological Suppression: A Randomized Controlled Trial. J Acquir Immune Defic Syndr. 2016; 72 Suppl 2:S124-9. PMC: 5113245. DOI: 10.1097/QAI.0000000000001062. View

5.
Haas A, Msukwa M, Egger M, Tenthani L, Tweya H, Jahn A . Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ Program. Clin Infect Dis. 2016; 63(9):1227-1235. PMC: 5064160. DOI: 10.1093/cid/ciw500. View